I am thrilled to be hosting a spot on the OBSERVER by Robert Lanza &
Nancy Kress Blog Tour hosted by Rockstar Book Tours. Check out my post and make sure to enter the giveaway!
About The Book:
Author: Robert Lanza & Nancy Kress
Pub. Date: January 10, 2023
Publisher: The Story Plant
Formats: Hardcover, eBook, Audiobook
Pages: 368
Find it: Goodreads, https://books2read.com/OBSERVER
EXCERPT
About Robert Lanza:
Robert Lanza is an American scientist and author whose research spans the
range of natural science, from biology to theoretical physics. TIME
magazine recognized him as one of the “100 Most Influential People in the
World,” and Prospect magazine named him one of the "Top 50 World
Thinkers.”
He has hundreds of scientific publications and over 30 books, including
definitive references in the fields of stem cells, tissue engineering, and
regenerative medicine. He is a former Fulbright Scholar, and studied with
polio-pioneer Jonas Salk and Nobel laureates Gerald Edelman (known for his
work on the biological basis of consciousness) and Rodney Porter. He also
worked closely (and co-authored papers in Science on self-awareness and
symbolic communication) with noted Harvard psychologist BF Skinner. Dr.
Lanza received his undergraduate and medical degrees from the University
of Pennsylvania, where he was both a University Scholar and Benjamin
Franklin Scholar.
Lanza was part of the team that cloned the world’s first human embryo,
the first endangered species, and published the first-ever reports of
pluripotent stem cell use in humans.
Lanza and his colleagues were also the first to demonstrate that nuclear
transplantation could be used to reverse the aging process and to generate
immune-compatible tissues, including the first organ tissue-engineered
from cloned cells. One of his early achievements was his demonstration
that techniques used in preimplantation genetic diagnosis could be used to
generate human embryonic stem cells without embryonic destruction.
He and colleagues have also succeeded in differentiating human
pluripotent stem cells into retinal cells, and has shown that they provide
long-term benefit in animal models of vision loss. Using this technology
some forms of blindness may be curable, including macular degeneration and
Stargardt disease, a currently untreatable form eye disease that causes
blindness in teenagers and young adults. Lanza's company received FDA
approval to carry out clinical trials in the US using them to treat
degenerative eye diseases, as well approval for the first human
pluripotent stem cell trial in Europe. The first patients reported
improved vision in the eyes treated with the cells, which The Guardian
said "represents a huge scientific achievement."
Dr. Lanza and his colleagues published the first-ever report of human
pluripotent stem cells transplanted into human patients. The patients who
received the stem cell transplants say their lives have been transformed
by the experimental procedure--they report that they can use their
computers, thread a needle, or even go to the mall or airport on their
own.
Lanza has also been a major player in the scientific revolution that has
led to the documentation that nuclear transfer/transcription factors can
restore developmental potential in a differentiated cell. One of his
successes was showing that it is feasible to generate functional
oxygen-carrying red blood cells from human pluripotent stem cells. The
blood cells were comparable to normal transfusable blood and could serve
as a potentially inexhaustible source of "universal" blood. His team also
discovered how to generate functional hemangioblasts - a population of
"ambulance" cells - from hES cells. In animals, these cells quickly
repaired vascular damage, cutting the death rate after a heart attack in
half and restoring the blood flow to ischemic limbs that might otherwise
have to be amputated.
Lanza and a team lead by Kwang-Soo Kim at Harvard University have also
reported a safe method for generating induced pluripotent stem (iPS)
cells. Human iPS cells were created from skin cells by direct delivery of
proteins, thus eliminating the harmful risks associated with genetic
manipulation. The Editors of the prestigious journal Nature selected Lanza
and Kim's paper on protein reprogramming as one of five "Research
Highlights." Discover magazine stated, "Lanza's single-minded quest to
usher in this new age has paid dividends in scientific insights and
groundbreaking discoveries." Fortune magazine called him "the
standard-bearer for stem cell research.”
Dr. Lanza has received numerous awards, including being named one of TIME
Magazine's "100 Most Influential People in the World"; the 2013 Il Leone
di San Marco award in Medicine (The Italian Heritage and Culture
Committee, along with Regis Philbin [in Entertainment]); including an NIH
Director's Award (2010) for "Translating Basic Science Discoveries into
New and Better Treatments"; the 2010 'Movers and Shakers' Who Will Shape
Biotech Over the Next 20 Years (BioWorld)(along with Craig Venter and
President Barack Obama); the 2007 100 Most Inspiring People in the
Life-Sciences Industry (PharmaVOICE, "For his discoveries 'behind the
medicines making a significant impact on the pipelines of today and of the
future'"; the 2007 Outstanding Contribution in Contemporary Biology Award
(Brown University, "For his groundbreaking research and contributions in
stem cell science and biology"; the 2006 All-Star Award for Biotechnology
(MA High Tech, for "pushing stem cells' future"); the 2005 Rave Award for
Medicine (Wired magazine, "For eye-opening work on embryonic stem cells");
and Lanza is listed in Who's Who in America, Who's Who in the World, Who's
Who in Medicine and Healthcare, Who's Who in Science and Engineering;
Who's Who in American Education, and Who's Who in Technology, among
others.
Dr. Lanza and his research have been featured in almost every media
outlet in the world, including CNN, TIME, Newsweek, People, as well as the
front pages of the New York Times, Wall Street Journal, Washington Post,
among others (his work has also been the cover story of US News &
World Report, Wired magazine, and Scientific American).
In 2007, Lanza published a feature article, "A New Theory of the
Universe" in The American Scholar, a leading intellectual journal which
has previously published works by Albert Einstein, Margaret Mead, and Carl
Sagan, among others. His theory places biology above the other sciences in
an attempt to solve one of nature's biggest puzzles, the theory of
everything that other disciplines have been pursuing for the last century.
This new view has become known as Biocentrism. In biocentrism, space and
time are forms of animal sense perception, rather than external physical
objects. Understanding this more fully yields answers to several major
puzzles of mainstream science, and offers a new way of understanding
everything from the microworld (for instance, the reason for Heisenberg's
uncertainty principle and the double-slit experiment) to the forces,
constants, and laws that shape the universe. Nobel laureate E. Donnall
Thomas stated "Any short statement does not do justice to such a scholarly
work. The work is a scholarly consideration of science and philosophy that
brings biology into the central role in unifying the whole."
You can read more about Dr. Robert Lanza's work at:
Website | Twitter | Facebook | Goodreads
|
Amazon
|
BookBub
Nancy Kress is the author of thirty-four books, including twenty-six
novels, four collections of short stories, and three books on writing. Her
work has won six Nebulas, two Hugos, a Sturgeon, and the John W. Campbell
Memorial Award. She writes frequently about genetic engineering; including
the acclaimed science-fiction novel Beggars in Spain. Kress’s fiction has
been translated into Swedish, Danish, French, Italian, German, Spanish,
Polish, Croatian, Chinese, Lithuanian, Romanian, Japanese, Korean, Hebrew,
Russian, and Klingon, none of which she can read. In addition to writing,
Kress often teaches at various venues around the country and abroad,
including a visiting lectureship at the University of Leipzig, a 2017
writing class in Beijing, and the annual intensive workshop TaosToolbox.
Kress lives in Seattle with her husband, writer Jack Skillingstead, and
Pippin, the world’s most spoiled Chihuahua.
Website | Goodreads
| Amazon |
BookBub
Giveaway Details:
1 winner will receive a $10 Amazon Gift Card, International.
Ends January 24th, midnight EST.
Tour Schedule:
Week One:
1/9/2023 |
Guest Post/IG Post |
|
1/9/2023 |
Guest Post |
|
1/10/2023 |
Excerpt/IG Post |
|
1/10/2023 |
Guest Post |
|
1/11/2023 |
Review |
|
1/11/2023 |
Excerpt |
|
1/12/2023 |
TikTok Review/IG Post |
|
1/12/2023 |
Review |
|
1/13/2023 |
IG Review/LFL Drop Pic |
|
1/13/2023 |
Review/IG Post |
Week Two:
1/16/2023 |
Facebook Review/IG Review |
|
1/16/2023 |
Guest Post/IG Post |
|
1/17/2023 |
IG Review |
|
1/17/2023 |
IG Review/TikTok Post |
|
1/18/2023 |
Excerpt/IG Post |
|
1/18/2023 |
Review/IG Post |
|
1/19/2023 |
Review/IG Post |
|
1/19/2023 |
Excerpt/IG Post |
|
1/20/2023 |
IG Review |
|
1/20/2023 |
Review |
No comments:
Post a Comment
Please try not to spam posts with the same comments over and over again. Authors like seeing thoughtful comments about their books, not the same old, "I like the cover" or "sounds good" comments. While that is nice, putting some real thought and effort in is appreciated. Thank you.